Table 3 Baseline characteristics of the patients before (entire cohort) and after propensity score matching (matched cohort)
Whole cohort | p valuea | Matched cohort | p valuea | |||
|---|---|---|---|---|---|---|
FT group (n = 184) | No-FT group (n = 133) | FT group (n = 119) | No-FT group (n = 119) | |||
Elderly patients (> 75) | 23 (13%) | 10 (8%) | 0.14b | 5 (4%) | 6 (5%) | 0.56b |
Gender (%) | 0.45b | 0.70b | ||||
Male | 163 (89%) | 114 (86%) | 104 (87%) | 102 (86%) | ||
Female | 23 (11%) | 21 (14%) | 14 (13%) | 15 (14%) | ||
Tumor location | 0.33b | 0.26b | ||||
Ut/Mt/Lt | 31/86/67 | 30/53/50 | 19/56/44 | 29/49/41 | ||
Depth of tumor invasion | 0.044b | 0.24b | ||||
cT1-2 | 107 (58%) | 92 (69%) | 91 (76%) | 83 (69%) | ||
cT3-4 | 77 (42%) | 41 (36%) | 28 (24%) | 36 (31%) | ||
Lymph node metastasis (cN+) | 101 (55%) | 64 (48%) | 0.23b | 57 (48%) | 56 (47%) | 0.89b |
Preoperative therapy (+) | 133 (72%) | 68 (51%) | 0.0001c | 49 (41%) | 52 (44%) | 0.69b |
Preoperative body weight (kg) | 56 (32–80) | 58 (36–85) | 0.21 c | 57 (32–79) | 58 (36–85) | 0.87c |
Anastomotic leakage* (+) | 22 (12%) | 13 (9.8%) | 0.53 | 17 (14%) | 11 (9.2%) | 0.23 |
Pulmonary complication* (+) | 11 (6%) | 7 (5.3%) | 0.79 | 4 (3.4%) | 4 (3.4%) | 1.00 |
Recurrent nerve palsy* (+) | 5 (2.7%) | 8 (6%) | 0.14 | 2 (1.7%) | 6 (5%) | 0.14 |